This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Ammonium tetrathiomolybdate
- DrugBank Accession Number
- DB17641
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Ammonium tetrathiomolybdate (DB17641)
- Weight
- Average: 260.27
Monoisotopic: 261.862438 - Chemical Formula
- H8MoN2S4
- Synonyms
- Ammonium molybdenum sulfide ((nh4)2mos4)
- Coprexa
- Diammonium tetrathiomolybdate
- Molybdate(2-), tetrathioxo-, ammonium (1:2), (t-4)-
- Molybdate(2-), tetrathioxo-, diammonium, (t-4)-
- Tiomolibdate diammonium
- External IDs
- ATT-M
- ATTM
- NSC-286644
- NSC-714598
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Adenosine Triphosphatases, antagonists & inhibitors
- Angiogenesis Inhibitors
- Angiogenesis Modulating Agents
- Antineoplastic Agents
- Chelating Agents
- Compounds used in a research, industrial, or household setting
- Elements
- Enzyme Inhibitors
- Growth Inhibitors
- Growth Substances
- Metals
- Metals, Heavy
- Sequestering Agents
- Transition Elements
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4V6I63LW1E
- CAS number
- 15060-55-6
- InChI Key
- PQNOIAHNKHBLRN-UHFFFAOYSA-P
- InChI
- InChI=1S/Mo.2H3N.4S/h;2*1H3;;;;/q;;;;;2*-1/p+2
- IUPAC Name
- diammonium (sulfanidyldisulfanylidenemolybdenio)sulfanide
- SMILES
- [NH4+].[NH4+].[S-][Mo]([S-])(=S)=S
References
- General References
- Not Available
- External Links
- ChemSpider
- 10764593
- Wikipedia
- Ammonium_tetrathiomolybdate
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data1 Withdrawn Treatment Lung Cancer 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 1.57 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 37.74 m3·mol-1 Chemaxon Polarizability 14.29 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at April 18, 2023 14:18 / Updated at April 20, 2023 07:02